In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: A comparative study to HGF

Journal of Hepatology

Volumn 44, Issue 6, 2006, Pages 1046-1054

  Khai, Ngin Cin ^a,b   Takahashi, Tomoyuki ^a,c   Ushikoshi, Hiroaki ^a,b   Nagano, Satoshi ^a,c,d   Yuge, Kentaro ^a   Esaki, Masayasu ^a,b   Kawai, Takao ^a,b   Goto, Kazuko ^a,b   Murofushi, Yoshiteru ^a,c   Fujiwara, Takako ^e   Fujiwara, Hisayoshi ^b   Kosai, Ken ichiro ^a,c,d  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Adenoviral vector; Apoptosis; Fas; Fulminant hepatic failure; Gene therapy; Growth factor; HB EGF; Heparin binding epidermal growth factor like growth factor; Hepatocyte growth factor; HGF; Liver regeneration

Indexed keywords

ADENOVIRUS VECTOR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FAS ANTIBODY; FAS ANTIGEN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; SCATTER FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG EFFECT; GENE THERAPY; GENETIC TRANSDUCTION; HISTOPATHOLOGY; LIVER CELL; LIVER INJURY; LIVER REGENERATION; MALE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE;

ADENOVIRIDAE; ANIMALS; ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; CELL MEMBRANE; EPIDERMAL GROWTH FACTOR; GENE THERAPY; HEPATOCYTE GROWTH FACTOR; LIVER; LIVER DISEASES; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; TRANSDUCTION, GENETIC;

EID: 33646149962     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.10.027     Document Type: Article

References (42)

1. Michalopoulos G.K. Liver regeneration: molecular mechanisms of growth control. Faseb J 4 (1990) 176-187
2. Fausto N., Laird A.D., and Webber E.M. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. Faseb J 9 (1995) 1527-1536
3. Matsumoto K., and Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239 (1997) 639-644
4. Roberts R.A., James N.H., and Cosulich S.C. The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor alpha-mediated rat hepatocyte survival and apoptosis. Hepatology 31 (2000) 420-427
5. Webber E.M., FitzGerald M.J., Brown P.I., Bartlett M.H., and Fausto N. Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor. Hepatology 18 (1993) 1422-1431
6. Birchmeier C., and Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8 (1998) 404-410
7. Fausto N. Liver regeneration. J Hepatol 32 (2000) 19-31
8. Pistoi S., and Morello D. Liver regeneration 7. Prometheus' myth revisited: transgenic mice as a powerful tool to study liver regeneration. Fed Am Soc Exp Biol J 10 (1996) 819-828
9. Ishiki Y., Ohnishi H., Muto Y., Matsumoto K., and Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16 (1992) 1227-1235
10. Matsuda Y., Matsumoto K., Ichida T., and Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem Tokyo 118 (1995) 643-649
11. Ueki T., Kaneda Y., Tsutsui H., Nakanishi K., Sawa Y., Morishita R., et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5 (1999) 226-230
12. Hwang T.H., Yoon B.C., Jeong J.S., Seo S.Y., and Lee H.J. A single administration of adenoviral-mediated HGF cDNA permits survival of mice from acute hepatic failure. Life Sci 72 (2003) 851-861
13. Kosai K.I., Finegold M.J., Thi-Huynh B.T., Tewson M., Ou C.N., Bowles N., et al. Retrovirus-mediated in vivo gene transfer in the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy. Hum Gene Ther 9 (1998) 1293-1301
14. Kosai K., Matsumoto K., Nagata S., Tsujimoto Y., and Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 244 (1998) 683-690
15. Kosai K., Matsumoto K., Funakoshi H., and Nakamura T. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 30 (1999) 151-159
16. Phaneuf D., Chen S.J., and Wilson J.M. Intravenous injection of an adenovirus encoding hepatocyte growth factor results in liver growth and has a protective effect against apoptosis. Mol Med 6 (2000) 96-103
17. Higashiyama S., Abraham J.A., Miller J., Fiddes J.C., and Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251 (1991) 936-939
18. Raab G., and Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333 (1997) F179-F199
19. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402 (1999) 884-888
20. Iwamoto R., and Mekada E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev 11 (2000) 335-344
21. Goishi K., Higashiyama S., Klagsbrun M., Nakano N., Umata T., Ishikawa M., et al. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell 6 (1995) 967-980
22. Ito N., Kawata S., Tamura S., Kiso S., Tsushima H., Damm D., et al. Heparin-binding EGF-like growth factor is a potent mitogen for rat hepatocytes. Biochem Biophys Res Commun 198 (1994) 25-31
23. Higashiyama S., Abraham J.A., and Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J Cell Biol 122 (1993) 933-940
24. Kiso S., Kawata S., Tamura S., Higashiyama S., Ito N., Tsushima H., et al. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy. Hepatology 22 (1995) 1584-1590
25. Kiso S., Kawata S., Tamura S., Ito N., Tsushima H., Yamada A., et al. Expression of heparin-binding EGF-like growth factor in rat liver injured by carbon tetrachloride or d-galactosamine. Biochem Biophys Res Commun 220 (1996) 285-288
26. Kiso S., Kawata S., Tamura S., Umeki S., Ito N., Tsushima H., et al. Effects of exogenous human heparin-binding epidermal growth factor-like growth factor on DNA synthesis of hepatocytes in normal mouse liver. Biochem Biophys Res Commun 259 (1999) 683-687
27. Kiso S., Kawata S., Tamura S., Inui Y., Yoshida Y., Sawai Y., et al. Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology 124 (2003) 701-707
28. Ushikoshi H., Takahashi T., Chen X., Khai N.C., Esaki M., Goto K., et al. Local overexpression of HB-EGF exacerbates remodeling following myocardial infarction by activating noncardiomyocytes. Lab Invest 85 (2005) 862-873
29. Yuge K., Takahashi T., Nagano S., Terazaki Y., Murofushi Y., Ushikoshi H., et al. Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatoma. Int J Oncol 27 (2005) 77-85
30. Chen S.H., Chen X.H., Wang Y., Kosai K., Finegold M.J., Rich S.S., et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci USA 92 (1995) 2577-2581
31. Terazaki Y., Yano S., Yuge K., Nagano S., Fukunaga M., Guo Z.S., et al. An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice. Hepatology 37 (2003) 155-163
32. Peeters M.J., Patijn G.A., Lieber A., Meuse L., and Kay M.A. Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration. Hum Gene Ther 7 (1996) 1693-1699
33. Oksuz M., Akkiz H., Isiksal Y.F., Saydaogluc G., Serin M., Kayaselcuk F., et al. Expression of Fas antigen in liver tissue of patients with chronic hepatitis B and C. Eur J Gastroenterol Hepatol 16 (2004) 341-345
34. Kondo T., Suda T., Fukuyama H., Adachi M., and Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nat Med 3 (1997) 409-413
35. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., et al. Lethal effect of the anti-Fas antibody in mice. Nature 364 (1993) 806-809
36. Ferrell L. Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems. Mod Pathol 13 (2000) 679-704
37. Mitchell C., Nivison M., Jackson L.F., Fox R., Lee D.C., Campbell J.S., et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem 280 (2005) 2562-2568
38. Kinoshita T., Tashiro K., and Nakamura T. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun 165 (1989) 1229-1234
39. Scheving L.A., Stevenson M.C., Taylormoore J.M., Traxler P., and Russell W.E. Integral role of the EGF receptor in HGF-mediated hepatocyte proliferation. Biochem Biophys Res Commun 290 (2002) 197-203
40. Inui Y., Higashiyama S., Kawata S., Tamura S., Miyagawa J., Taniguchi N., et al. Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma. Gastroenterology 107 (1994) 1799-1804
41. Miyoshi E., Higashiyama S., Nakagawa T., Suzuki K., Horimoto M., Hayashi N., et al. High expression of heparin-binding EGF-like growth factor in rat hepatocarcinogenesis. Int J Cancer 68 (1996) 215-218
42. Kiso S., Kawata S., Tamura S., Miyagawa J., Ito N., Tsushima H., et al. Expression of heparin-binding epidermal growth factor-like growth factor in the hepatocytes of fibrotic rat liver during hepatocarcinogenesis. J Gastroenterol Hepatol 14 (1999) 1203-1209